ANGELA KURIAKOSE: Open Payments
NPI 1619751773 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,403 in 145 payments from 19 companies in 2025. Trend: 2023 $348 · 2024 $2,715 · 2025 $3,403
Food & beverage: $3,178Education: $225
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 18 | $969 |
| ARS Pharmaceuticals Operations, Inc. | 22 | $575 |
| AstraZeneca Pharmaceuticals LP | 17 | $378 |
| GlaxoSmithKline, LLC. | 28 | $241 |
| Amgen Inc. | 14 | $234 |
| BioCryst US Sales Co., LLC | 11 | $215 |
| Novartis Pharmaceuticals Corporation | 8 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $136 |
| CSL Behring | 3 | $95 |
| Genentech USA, Inc. | 3 | $78 |
Products named: DUPIXENT, NEFFY, TEZSPIRE, ORLADEYO, FASENRA, TRELEGY ELLIPTA, XOLAIR, NUCALA.
Industry payments across NC — which companies pay providers there.
